Alfuzosin听is a medication of the 伪1 blocker class. It is used to treat benign prostatic hyperplasia (BPH).听
The global Alfuzosin market is projected to grow from US$ 91 million in 2024 to US$ 117.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
Alfuzosin is a medication primarily used to treat the symptoms of benign prostatic hyperplasia (BPH), a condition where the prostate gland enlarges and causes urinary difficulties. It belongs to a class of drugs called alpha-adrenergic blockers, which relax the muscles in the prostate and bladder neck, allowing for improved urine flow. Benign prostatic hyperplasia is a common condition, especially among older men. The increasing aging population contributes to a higher demand for medications like alfuzosin that effectively manage BPH symptoms. As awareness about BPH and its symptoms grows, more individuals seek medical help and treatment options. This drives the demand for medications like alfuzosin. Technological advancements, improved diagnostics, and enhanced treatment options have led to better detection and management of BPH, resulting in increased adoption of medications like alfuzosin. While alfuzosin is effective, there are other medications available for managing BPH symptoms. Competition among different medications in the market can drive the innovation and marketing efforts of manufacturers, resulting in increased demand for alfuzosin. Higher healthcare expenditure and accessibility to healthcare facilities in many regions further contribute to the growth of the alfuzosin market.
Report Covers:
This report presents an overview of global market for Alfuzosin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Alfuzosin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Alfuzosin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Alfuzosin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Alfuzosin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Alfuzosin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Apotex
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
Wockhardt
Unichem Laboratories
Cipla
Segment by Type
2.5mg Tablets
10mg Tablets
Segment by Application
Hospital
Drug store
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Alfuzosin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Alfuzosin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alfuzosin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Alfuzosin Product Introduction
1.2 Market by Type
1.2.1 Global Alfuzosin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 2.5mg Tablets
1.2.3 10mg Tablets
1.3 Market by Application
1.3.1 Global Alfuzosin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alfuzosin Sales Estimates and Forecasts 2019-2030
2.2 Global Alfuzosin Revenue by Region
2.2.1 Global Alfuzosin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Alfuzosin Revenue by Region (2019-2024)
2.2.3 Global Alfuzosin Revenue by Region (2025-2030)
2.2.4 Global Alfuzosin Revenue Market Share by Region (2019-2030)
2.3 Global Alfuzosin Sales Estimates and Forecasts 2019-2030
2.4 Global Alfuzosin Sales by Region
2.4.1 Global Alfuzosin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Alfuzosin Sales by Region (2019-2024)
2.4.3 Global Alfuzosin Sales by Region (2025-2030)
2.4.4 Global Alfuzosin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Alfuzosin Sales by Manufacturers
3.1.1 Global Alfuzosin Sales by Manufacturers (2019-2024)
3.1.2 Global Alfuzosin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alfuzosin in 2023
3.2 Global Alfuzosin Revenue by Manufacturers
3.2.1 Global Alfuzosin Revenue by Manufacturers (2019-2024)
3.2.2 Global Alfuzosin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Alfuzosin Revenue in 2023
3.3 Global Key Players of Alfuzosin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Alfuzosin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Alfuzosin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Alfuzosin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Alfuzosin, Product Offered and Application
3.8 Global Key Manufacturers of Alfuzosin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alfuzosin Sales by Type
4.1.1 Global Alfuzosin Historical Sales by Type (2019-2024)
4.1.2 Global Alfuzosin Forecasted Sales by Type (2025-2030)
4.1.3 Global Alfuzosin Sales Market Share by Type (2019-2030)
4.2 Global Alfuzosin Revenue by Type
4.2.1 Global Alfuzosin Historical Revenue by Type (2019-2024)
4.2.2 Global Alfuzosin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Alfuzosin Revenue Market Share by Type (2019-2030)
4.3 Global Alfuzosin Price by Type
4.3.1 Global Alfuzosin Price by Type (2019-2024)
4.3.2 Global Alfuzosin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Alfuzosin Sales by Application
5.1.1 Global Alfuzosin Historical Sales by Application (2019-2024)
5.1.2 Global Alfuzosin Forecasted Sales by Application (2025-2030)
5.1.3 Global Alfuzosin Sales Market Share by Application (2019-2030)
5.2 Global Alfuzosin Revenue by Application
5.2.1 Global Alfuzosin Historical Revenue by Application (2019-2024)
5.2.2 Global Alfuzosin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Alfuzosin Revenue Market Share by Application (2019-2030)
5.3 Global Alfuzosin Price by Application
5.3.1 Global Alfuzosin Price by Application (2019-2024)
5.3.2 Global Alfuzosin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Alfuzosin Market Size by Type
6.1.1 US & Canada Alfuzosin Sales by Type (2019-2030)
6.1.2 US & Canada Alfuzosin Revenue by Type (2019-2030)
6.2 US & Canada Alfuzosin Market Size by Application
6.2.1 US & Canada Alfuzosin Sales by Application (2019-2030)
6.2.2 US & Canada Alfuzosin Revenue by Application (2019-2030)
6.3 US & Canada Alfuzosin Market Size by Country
6.3.1 US & Canada Alfuzosin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Alfuzosin Sales by Country (2019-2030)
6.3.3 US & Canada Alfuzosin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Alfuzosin Market Size by Type
7.1.1 Europe Alfuzosin Sales by Type (2019-2030)
7.1.2 Europe Alfuzosin Revenue by Type (2019-2030)
7.2 Europe Alfuzosin Market Size by Application
7.2.1 Europe Alfuzosin Sales by Application (2019-2030)
7.2.2 Europe Alfuzosin Revenue by Application (2019-2030)
7.3 Europe Alfuzosin Market Size by Country
7.3.1 Europe Alfuzosin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Alfuzosin Sales by Country (2019-2030)
7.3.3 Europe Alfuzosin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Alfuzosin Market Size
8.1.1 China Alfuzosin Sales (2019-2030)
8.1.2 China Alfuzosin Revenue (2019-2030)
8.2 China Alfuzosin Market Size by Application
8.2.1 China Alfuzosin Sales by Application (2019-2030)
8.2.2 China Alfuzosin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Alfuzosin Market Size by Type
9.1.1 Asia Alfuzosin Sales by Type (2019-2030)
9.1.2 Asia Alfuzosin Revenue by Type (2019-2030)
9.2 Asia Alfuzosin Market Size by Application
9.2.1 Asia Alfuzosin Sales by Application (2019-2030)
9.2.2 Asia Alfuzosin Revenue by Application (2019-2030)
9.3 Asia Alfuzosin Sales by Region
9.3.1 Asia Alfuzosin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Alfuzosin Revenue by Region (2019-2030)
9.3.3 Asia Alfuzosin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Alfuzosin Market Size by Type
10.1.1 Middle East, Africa and Latin America Alfuzosin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Alfuzosin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Alfuzosin Market Size by Application
10.2.1 Middle East, Africa and Latin America Alfuzosin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Alfuzosin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Alfuzosin Sales by Country
10.3.1 Middle East, Africa and Latin America Alfuzosin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Alfuzosin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Alfuzosin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Mylan
11.1.1 Mylan Company Information
11.1.2 Mylan Overview
11.1.3 Mylan Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Mylan Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mylan Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Teva Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Overview
11.3.3 Apotex Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Apotex Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Apotex Recent Developments
11.4 Torrent Pharmaceuticals
11.4.1 Torrent Pharmaceuticals Company Information
11.4.2 Torrent Pharmaceuticals Overview
11.4.3 Torrent Pharmaceuticals Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Torrent Pharmaceuticals Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Torrent Pharmaceuticals Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Company Information
11.5.2 Sun Pharma Overview
11.5.3 Sun Pharma Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sun Pharma Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharma Recent Developments
11.6 Aurobindo
11.6.1 Aurobindo Company Information
11.6.2 Aurobindo Overview
11.6.3 Aurobindo Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Aurobindo Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Aurobindo Recent Developments
11.7 Wockhardt
11.7.1 Wockhardt Company Information
11.7.2 Wockhardt Overview
11.7.3 Wockhardt Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Wockhardt Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Wockhardt Recent Developments
11.8 Unichem Laboratories
11.8.1 Unichem Laboratories Company Information
11.8.2 Unichem Laboratories Overview
11.8.3 Unichem Laboratories Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Unichem Laboratories Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Unichem Laboratories Recent Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla Overview
11.9.3 Cipla Alfuzosin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Cipla Alfuzosin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alfuzosin Industry Chain Analysis
12.2 Alfuzosin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alfuzosin Production Mode & Process
12.4 Alfuzosin Sales and Marketing
12.4.1 Alfuzosin Sales Channels
12.4.2 Alfuzosin Distributors
12.5 Alfuzosin Customers
13 Market Dynamics
13.1 Alfuzosin Industry Trends
13.2 Alfuzosin Market Drivers
13.3 Alfuzosin Market Challenges
13.4 Alfuzosin Market Restraints
14 Key Findings in The Global Alfuzosin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Mylan
Teva
Apotex
Torrent Pharmaceuticals
Sun Pharma
Aurobindo
Wockhardt
Unichem Laboratories
Cipla
听
听
*If Applicable.